Seres Therapeutics, Inc. (MCRB) is a publicly traded Healthcare sector company. As of May 21, 2026, MCRB trades at $7.79 with a market cap of $73.50M and a P/E ratio of -1.45. MCRB moved +1.88% today. Year to date, MCRB is -49.57%; over the trailing twelve months it is -7.04%. Its 52-week range spans $6.53 to $29.98. Analyst consensus is buy with an average price target of $22.00. Rallies surfaces MCRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MCRB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MCRB recently traded at $7.79. Market cap is $73.50M. P/E ratio is -1.45. Revenue is $1.15M.
| Metric | Value |
|---|---|
| Price | $7.79 |
| Market Cap | $73.50M |
| P/E Ratio | -1.45 |
| EPS | $-5.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.98 |
| 52-Week Low | $6.53 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.15M |
| Net Income | $-46.90M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $789.00K | $5.70M | $0.64 |
| 2024 | $0 | $136.00K | $0.00 |
| 2023 | $126.33M | $-113.72M | $-0.89 |
| 2022 | $7.13M | $-250.16M | $-2.31 |
1 analysts cover MCRB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $22.00.